Tarrytown, NY (PRWEB) August 26, 2013
The Life Support Technologies Group (LST) has installed two (2) additional hyperbaric chambers at the Center for Advanced Wound Healing and Hyperbaric Medicine, Saint Francis Hospital and Medical Center, Mount Sinai Campus, Hartford, CT, thereby increasing patient treatment capacity by 100%. These chambers enable patients to be treated at increased atmospheric pressure while they breathe oxygen. Benefits of hyperbaric treatment include faster wound healing, increased tissue oxygenation, enhanced immune system function, bactericide, and faster capillary budding around and within injured tissue.
Laurie Anne Loiacono, M.D., Director of the Center for Advanced Wound Healing and Hyperbaric Medicine at Saint Francis Hospital and Medical Center, said, “The additional hyperbaric chambers are needed in order to keep pace with demand and to continue to provide advanced wound care and hyperbaric treatment for our patients.”
Hyperbaric treatment involves placing a patient in a pressurized environment known as a hyperbaric chamber and having them breathe 100% oxygen. Hyperbaric chamber construction standards are established and published by the American Society of Mechanical Engineers (ASME) Pressure Vessel for Human Occupancy (PVHO) Committee. Monoplace hyperbaric chambers are the most common and are designed to treat one patient at a time. Multiplace chambers are purpose-built and can accommodate as many patients as they are built for.
LST installed Environmental Tectonics Corporation’s (ETC) latest monoplace hyperbaric chamber model, known as the Select. ETC is the manufacturer of the world’s first computer-driven hyperbaric chambers.
Currently, in the United States, the Centers for Medicare and Medicaid Services (CMS) approve hyperbaric treatment for fifteen (15) medical indications. Most commercial insurance carriers follow CMS guidelines for hyperbaric treatment reimbursement. Conditions covered by CMS include: acute carbon monoxide intoxication; decompression illness; gas embolism; gas gangrene; acute traumatic peripheral ischemia; crush injuries and suturing of severed limbs; progressive necrotizing infections (necrotizing fasciitis); acute peripheral arterial insufficiency; preparation and preservation of compromised skin grafts (not for primary management of wounds); chronic refractory osteomyelitis, unresponsive to conventional medical and surgical management; osteoradionecrosis as an adjunct to conventional treatment; soft tissue radionecrosis as an adjunct to conventional treatment; cyanide poisoning; actinomycosis, only as an adjunct to conventional therapy when the disease process is refractory to antibiotics and surgical treatment; diabetic wounds of the lower extremities in patients who meet certain criteria.
For more information see:
Center for Advanced Wound Healing and Hyperbaric Medicine, Saint Francis Hospital and Medical Center, Mount Sinai Campus, Hartford, CT
American Society of Mechanical Engineers (ASME)
Environmental Tectonics Corporation (ETC) Biomedical Systems
Centers for Medicare and Medicaid Services (CMS)
About the Life Support Technologies Group (LST)
The Life Support Technologies Group (LST) is a Tarrytown, NY-based medical and life-support engineering company specializing in Advanced Wound Care and Hyperbaric Medicine Services to hospitals in the NY, NJ, CT region. LST has been in business for 20 years and currently provides services to 9 hospitals.
Glenn Butler, CEO
Life Support Technologies Group
Read the full story at http://www.prweb.com/releases/2013/8/prweb11053511.htm.
Copyright©2012 Vocus, Inc.
All rights reserved